Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01954901 · ClinicalTrials.gov registry record · NA
Hyperbaric Oxygen for Wagner II Diabetic Lower Extremity Ulcers
A NA study, sponsored by David Grant U.S. Air Force Medical Center.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT01954901 is a NA study that was terminated before completion, run by David Grant U.S. Air Force Medical Center. The registered enrollment target is 2 participants.
The verdict
NCT01954901, a NA study, was terminated before completion, sponsored by David Grant U.S. Air Force Medical Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
The purpose of this proposed DoD study is to determine if hyperbaric oxygen therapy (HBOT) plus standard wound care is more effective than standard wound care alone in the rate of healing and prevention of major amputation (metatarsal and proximal) in Wagner grade 2 diabetic lower extremity ulcers.
Interventions
- DEVICE Hyperbaric oxygen therapy
- DEVICE Hyperbaric room air
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2013-10 |
| Est. Completion | 2015-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01954901
The ClinicalTrials.gov registry entry for NCT01954901 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is David Grant U.S. Air Force Medical Center, which has 21 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Hyperbaric oxygen therapy is the first listed.
NCT01954901 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01954901 about?
NCT01954901 is a clinical study titled "Hyperbaric Oxygen for Wagner II Diabetic Lower Extremity Ulcers". The purpose of this proposed DoD study is to determine if hyperbaric oxygen therapy (HBOT) plus standard wound care is more effective than standard wound care alone in the rate of healing and prevention of major amputation (metatarsal and proximal) in Wagner grade 2 diabetic lower extremity ulcers.
What is the current status of trial NCT01954901?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2013-10. Estimated completion is 2015-08.
What interventions are being tested in trial NCT01954901?
The interventions under investigation include: Hyperbaric oxygen therapy (DEVICE), Hyperbaric room air (DEVICE).
Who is sponsoring clinical trial NCT01954901?
This trial is sponsored by David Grant U.S. Air Force Medical Center, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.